Comment from Sanfilippo Initiative

Summary: The Sanfilippo Initiative, representing the Sanfilippo patient community, supports the Plausible Mechanism Framework as a necessary approach for developing therapies for ultra-rare diseases. They urge the FDA to ensure the framework applies to all therapeutic modalities (such as enzyme replacement and small molecules) and to provide flexibility regarding biomarkers and natural history data in small patient populations.